These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 862206)

  • 21. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
    Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
    Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
    Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.
    Starke A; Keck E; Berger M; Zimmermann H
    Diabetologia; 1981 May; 20(5):547-52. PubMed ID: 7026328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal alpha cell function in diabetics response to insulin.
    Unger RH; Madison LL; Muller WA
    Diabetes; 1972 May; 21(5):301-7. PubMed ID: 24683634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
    Quddusi S; Vahl TP; Hanson K; Prigeon RL; D'Alessio DA
    Diabetes Care; 2003 Mar; 26(3):791-8. PubMed ID: 12610039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon suppression with low-dose intramuscular insulin therapy in diabetic ketoacidosis.
    Onur K; Lala VR; Juan CS; AvRuskin TW
    J Pediatr; 1979 Feb; 94(2):307-11. PubMed ID: 105114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.
    Meneilly GS; McIntosh CH; Pederson RA; Habener JF; Ehlers MR; Egan JM; Elahi D
    Diabetes Care; 2003 Mar; 26(3):837-42. PubMed ID: 12610046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oxytocin delivery on counter-regulatory hormone response in insulin-dependent (type 1) diabetic subjects.
    Paolisso G; Sgambato S; Giugliano D; Pizza G; Tesauro P; Varricchio M; D'Onofrio F
    Horm Res; 1989; 31(5-6):250-5. PubMed ID: 2693310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia.
    Lorenzi M; Bohannon N; Tsalikian E; Karam JH
    West J Med; 1984 Oct; 141(4):467-71. PubMed ID: 6390972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.
    Nyholm B; Orskov L; Hove KY; Gravholt CH; Møller N; Alberti KG; Moyses C; Kolterman O; Schmitz O
    Metabolism; 1999 Jul; 48(7):935-41. PubMed ID: 10421239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pharmacologic hyperglucagonemia on plasma amino acid concentrations in normal and diabetic man.
    Liljenquist JE; Lewis SB; Cherrington AD; Sinclair-Smith BC; Lacy WW
    Metabolism; 1981 Dec; 30(12):1195-9. PubMed ID: 7031418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus.
    Raskin P; Aydin I; Unger RH
    Diabetes; 1976 Mar; 25(3):227-9. PubMed ID: 1254112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
    Asplin CM; Paquette TL; Palmer JP
    J Clin Invest; 1981 Jul; 68(1):314-8. PubMed ID: 7019246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.